CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 144 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2016. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $62,000 | +47.6% | 26,749 | +79.1% | 0.00% | – |
| Q4 2017 | $42,000 | -64.1% | 14,935 | -63.5% | 0.00% | -100.0% |
| Q3 2017 | $117,000 | +74.6% | 40,906 | +50.6% | 0.00% | 0.0% |
| Q2 2017 | $67,000 | -19.3% | 27,160 | +18.4% | 0.00% | 0.0% |
| Q1 2017 | $83,000 | -64.5% | 22,939 | -65.3% | 0.00% | -50.0% |
| Q4 2016 | $234,000 | +88.7% | 66,198 | +101.2% | 0.00% | +100.0% |
| Q1 2016 | $124,000 | -41.8% | 32,904 | +62.7% | 0.00% | 0.0% |
| Q3 2015 | $213,000 | -72.6% | 20,221 | -34.3% | 0.00% | -80.0% |
| Q2 2015 | $776,000 | +57.7% | 30,761 | +74.2% | 0.01% | +66.7% |
| Q1 2015 | $492,000 | +25.8% | 17,656 | -17.5% | 0.00% | +50.0% |
| Q4 2014 | $391,000 | -23.5% | 21,406 | -26.0% | 0.00% | 0.0% |
| Q1 2014 | $511,000 | +221.4% | 28,937 | +341.6% | 0.00% | +100.0% |
| Q4 2013 | $159,000 | -73.2% | 6,553 | -60.9% | 0.00% | -50.0% |
| Q3 2013 | $594,000 | – | 16,767 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Byrne Asset Management LLC | 86 | $2,000 | 0.00% |